New Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014
June 19, 2014 09:00 ET
|
Corcept Therapeutics
CHICAGO, IL--(Marketwired - Jun 19, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Announces First Quarter 2014 Financial Results
May 07, 2014 08:30 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - May 7, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call
April 30, 2014 16:30 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Apr 30, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May...
US Oncology Research Joins Corcept Therapeutics' Phase I Breast Cancer Study
April 02, 2014 12:15 ET
|
Corcept Therapeutics
MENLO PARK, CA and THE WOODLANDS, TX--(Marketwired - Apr 2, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and...
Corcept Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results
March 05, 2014 09:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Mar 5, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics Announces Fourth Quarter, Full Year 2013 Revenue and Provides 2014 Outlook
January 30, 2014 16:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Jan 30, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT)
Fourth quarter 2013 revenue up 56% over third quarter 2013 revenue
...
Corcept Therapeutics to Announce Fourth Quarter and Full Year Revenue and Corporate Update and Host Conference Call
January 27, 2014 08:30 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Jan 27, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full year 2013 revenue on January 30, 2014....
Corcept Therapeutics Announces Oncology Development Program
December 12, 2013 08:30 ET
|
Corcept Therapeutics
SAN ANTONIO, TX--(Marketwired - Dec 12, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for...
Corcept Therapeutics Announces Third Quarter 2013 Financial Results and Corporate Update
November 07, 2013 16:38 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Nov 7, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the...
Corcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call
November 04, 2013 17:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwired - Nov 4, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter 2013 financial results on November 7, 2013. The Company...